Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicing
Cristina Montero‐Conde(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Guillermo Pita(Spanish National Cancer Research Centre), Andrés Pérez‐Barrios(Centro de Biología Molecular Severo Ochoa), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Fátima Al‐Shahrour(Broad Institute), Javier Lanillos(Spanish National Cancer Research Centre), Rafael Torres‐Pérez(Spanish National Cancer Research Centre), Carles Zafón(Vall d'Hebron Hospital Universitari), Anna González‐Neira(Spanish National Cancer Research Centre), Javier Muñoz(Ikerbasque), Eduardo Zarzuela(Spanish National Cancer Research Centre), Garcilaso Riesco‐Eizaguirre(Universidad Francisco de Vitoria), Sonsoles Guadalix(Research Institute Hospital 12 de Octubre), Juan María Roldán‐Romero(European Bioinformatics Institute), Bruna Calsina(Spanish National Cancer Research Centre), Rita María Regojo(Hospital Universitario La Paz), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), Alfonso Cordero‐Barreal(Spanish National Cancer Research Centre), Guillermo Martín‐Serrano(Spanish National Cancer Research Centre), Federico Hawkins(Hospital Universitario 12 De Octubre), María Santos(Spanish National Cancer Research Centre), Osvaldo Graña‐Castro(Spanish National Cancer Research Centre), Laura Remacha(Spanish National Cancer Research Centre), Isabel López de Silanes(Institució Catalana de Recerca i Estudis Avançats), Alberto Cascón(Spanish National Cancer Research Centre), Marı́a A. Blasco(Spanish National Cancer Research Centre), Mireia Jordà(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Almudena Guerrero‐Álvarez(Hospital Universitario 12 De Octubre), Rocío Letón, Ángel M. Martínez‐Montes(Spanish National Cancer Research Centre), Luis J. Leandro‐García(Spanish National Cancer Research Centre)
Cited by 40
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
|Nature Genetics|2013|544
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Comprehensive molecular characterization of mitochondrial genomes in human cancers
|Nature Genetics|2020|520